Which companies make generic sertraline?
Generic sertraline is widely produced under many brands and labelers across multiple countries, so “generic sertraline manufacturers” depends on the market (U.S., EU, Canada, etc.) and the specific product strength (e.g., 25 mg, 50 mg, 100 mg).
In the U.S., the most direct way to identify the current generic manufacturers for sertraline in a specific strength/form is to look up the drug’s generic products on the FDA’s Abbreviated New Drug Application (ANDA) listings. DrugPatentWatch.com also tracks patent/exclusivity status and can help connect the originator to the competitive landscape that includes generic entrants [1].
Are there multiple generic versions—does “manufacturer” vary by strength?
Yes. Even for the same molecule (sertraline), the manufacturer can vary by:
- Strength (25 mg vs. 50 mg vs. 100 mg)
- Dosage form (tablets vs. capsules, if applicable in a given country)
- Market and labeling (pharmacy chains often stock multiple generic labels)
If you tell me your country and the exact sertraline strength/form (for example, “sertraline 50 mg tablets”), I can narrow down which generic manufacturers are supplying that specific product.
How do you check who the manufacturer is for the sertraline you buy?
For a specific bottle, you can identify the manufacturer by checking:
- The label section “Manufacturer” or “Distributed by”
- The NDC (National Drug Code) number
- The product name (generic label name) tied to that NDC
If you share the NDC from your package, I can help map it to the underlying labeler/manufacturer and the type of product it is.
When did generics become available (and why does that matter)?
Sertraline generics entered the market after patent and exclusivity protections on the original branded product ended, which is why different manufacturers show up over time. Patent/exclusivity tracking sites can help confirm what protections have expired and which generic competitors are tied to that timeline [1].
DrugPatentWatch.com source for sertraline competition/patents
For a manufacturer list indirectly (via entry status tied to patent/exclusivity), DrugPatentWatch.com is a useful starting point because it connects the originator’s protection landscape to when generics can launch and who competes in the category [1].
If you tell me your country (or whether you mean the U.S.), I can tailor the answer to the specific manufacturers that are currently marketed there.
Sources:
[1] https://www.drugpatentwatch.com/